CHERRIES

Track record

Selected, structured and executed investments for our clients:

Private Equity

Description: engineering and manufacturing tech company, leader in critical and special fasteners, precision parts and integrated systems

Sector: Aerospace & Defence

Year: 2020

Deal: Minority Expansion – Equity, Convertible Bond

Status: Active

Website: www.poggipolini.it

Description: engineering and production of hairpin technology automated lines for electric motors, as well as testing and assembling manufacturing

Sector: Automotive

Year: 2020

Deal: Minority Expansion – Equity, Convertible Bond

Status: Active

Website: www.tecnomatic.it

Description: leader in research, development and production of advanced phytomolecules for feed and pet animal health solutions

Sector: Health & Care

Year: 2023

Deal: Minority Expansion – Equity

Status: Active

Website: www.awpint.com

Description: global player for chauffeur premium mobility through a digital software for enterprise clients managing a global community of drivers 

Sector: Software

Year: 2024

Deal: Minority Expansion – Equity, Debt

Status: Active

Website: www.limolane.com



Tactical Investments

Description: Artificial intelligence asset management platform, provider of investment solutions for leading global banks and financial institutions

Sector: Fintech

Year: 2019

Deal: Minority Growth – Equity

Status: Active

Website: www.mdotm.ai

Description: global tech leader in app development, serving over a billion of users with its premium products such as Splice, Remini, Issuu, Evernote, WeTransfer.

Sector: Digital

Year: 2021

Deal: Minority Growth – Equity

Status: Active, Partially Exited

Website: www.bendingspoons.com

Description: luxury sustainable fashion brand mainly focused on beachwear apparel and direct stores in the top luxury turism locations

Sector: Fashion, Luxury

Year: 2022

Deal: Minority Growth – Equity

Status: Active

Website: www.kampos.com

Description: Swiss biotech company focusing on innovation of bio regenerative skin medicine

Sector: Biotech

Year: 2024

Deal: Minority Growth – Equity

Status: Active

Website: www.cutiss.swiss